7Ausma J,Wijffels M,Thone F,et al.Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation . 1997
8Wijffels M C E F,Kirchhof C J H J,Dorland R,et al.Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goat. Circulation . 1995
9Braunwald E.Management of heart failure. Heart Disease . 1997
4Matsuura A, Yamochi W, Hirata K, et al. Stimulatory interaction between vascular endothelial growth factor and endothelin-1 on each gene expression[J].Hypertension, 1998,32: 89-95.
5Pedersen OD, Bagger H, Kober L,et al. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction[J]. Circulation, 1999,100: 376-380.
6Madrid AH,Bueno MG,Rebollo Jose MG,et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study[J]. Circulation,2002,106: 331-336.
7Danish Li ,Shinagawa K ,Pang Li ,et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogswith ventricular tachypacing-induced congestive heart failure[J]. Circulation, 2001,104 : 2608-2614.
8Ausma J, Wijffels M, Thone F, et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat [J]. Circulation, 1997,96 : 3157-3163.
9Wijffels MCEF, Kirchhof CJHJ, Dorland R, et al.Atrial fibrillation begets atrial fibrillation: A study in awake chronically in strumented goats [J]. Circulation, 1995,92 : 1954-1968,.
10Kanapuli SP,Kumar A. Molecular cloning of human angiotensinogen cDNA and evidence for the presence of its mRNA in rat heart[J]. Circ Res,1987,6:786-790.
4Ji Q, Mei Y, Wang X, et al. Combination of irbesartan and amioda- rone to maintain sinus rhythm in patients with persistent atrial fibril- lation after rheumatic valve replacement [ J ]. Circ J, 2010,74 ( 9 ) : 1873 - 1879.
5Madrid AH, Marin IM, Cervantes CE, et al. Prevention of recurrences in patients with lone atrial fibrillation. The dose - dependent effect of angiotensin II receptor blockers [ J ]. J Renin Angiotensin Aldoste- rone Syst,2004,5(3) :114 -20.
6Madrid AH, Matin IM, Cervantes CE, et al. Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockers [ J ]. J Renin Angiotensin Aldoste- rone Syst,2004,5(3) :114 -120.
7Goette A, Arndt M, Rocken C, et al. Regulation of angiotensin I1 receptorsubtypes during atrial fibrillation in humans[J]. Circulation, 012, 101(8): 2678-2681.
8Anand K, Mooss AN, Hee TY, et al. Meta-analysis! inhibition of renin-angiotens in system prevents new-onset atrial fibrillation[J]. Am Heart J, 2011, 152(9): 217-222.
9TURHAN H, AKSOY Y, YETKIN E, et al. The impact of inflammation on the development, successfill eardioversion, recurrence and/or perpetuation of atrial fibrillation[J]. Int J Cardiol, 2007, 118(13): 256-257.
10SEHIFRIN E L. Beyond Blood pressure: The endothdium and atherose lerosis progression[J]. Am J Hypertention, 2002, 15(8): 115-119.
